Interview: Mehul Shah, Managing Director, Encube Ethicals, India
The managing director of Encube Ethicals discusses contract manufacturing in India today, growing competition from…
Encube Ethicals
Last updated: 13.02.2014
Address: Unit No. 24, Steelmade Industrial Estate, Marol, Andheri (East), Mumbai – 400 059. India.,India
Tel: +91-22-2920 4335
Web: http://www.encubeethicals.com/
Company description
Encube Ethicals is a progressive contract manufacturing company dedicated to the topical preparations viz. Creams, Ointments, Gels, Lotions and Solutions.
We have chosen TOPICALS
We are PROBABLY the only and largest Contract Manufacturing facility in India dedicated exclusively to manufacture Topical Preparations like Ointments,Creams,Gels & Solutions.
Our facility is approved as per ISO 9001:2000, WHO-GMP and Internationally by UAE, UKRAINE, HPFBI-CANADA, TGA-AUSTRALIA & JAPANESE FDA ( FOR OTC PRODUCTS)
Our vision is backed by a strong R&D team which continuosly meet new challenges in Dermatology.
All the functions of the plant & Corporate office are integrated on and are connected by leased lines.
Products and services
Lotions
Creams
Ointments
Interviews
Related
India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
India / Pharma Market to Grow by 12-14% Up to 2023
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
India / Six Companies at the Forefront of COVID-19 Vaccine Development
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
Supply Chain / Indian Pharma Manufacturing: Back in Business
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
News Roundup / Indian Pharma: January 2020
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
India / Biocon's New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
Gujarat / The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Pharma Faces / Vivek Sharma, PPS
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
China: Indian Pharma Firms Incoming
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
